RDY · CIK 0001135951 · FY2026 live · 2026-03-31
DR REDDYS LABORATORIES LTD
View as
Model
Classic Z
FY2026
1.15
Zone
Distress
Prior
—
Market DD
—
1y PD
—
Meridian Rank
58
0–100 · Classic Z tape · not a PD
Book standing
49
Year change
—
Market PD
—
O-score
82
Events on this name
Same published rows as Today. Not a live recompute.
Market PD unavailable
watch · 41
1.15
Z″ 2.01
Score 1.15 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.001.2 × = 0.00X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
0.001.4 × = 0.00X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
0.003.3 × = 0.00X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
1.910.6 × = 1.15X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.001 × = 0.00
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
DR REDDYS LABORATORIES LTD is on classic Z at 1.15 (distress) for FY2026, from an SEC 10-K. Book equity / liabilities is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 69th percentile in Healthcare.
- TRDADistressEntrada Therapeutics, Inc.1.15
- DCTHDistressDELCATH SYSTEMS, INC.1.15
- INDVDistressIndivior Pharmaceuticals, Inc.1.16
- RPRXDistressRoyalty Pharma plc1.19
- TARSDistressTarsus Pharmaceuticals, Inc.1.09
- NAIIDistressNATURAL ALTERNATIVES INTERNATIONAL INC1.09
- RLAYDistressRelay Therapeutics, Inc.1.21
- CBIODistressCRESCENT BIOPHARMA, INC.1.22
KPI widgets
Current assets
$0
Total assets
$6.2B
Current liabilities
$0
Total liabilities
$2.1B
Working capital
$0
Retained earnings
$0
EBIT
$0
Total sales
$0
Book equity
$4.1B
Accession 0001575872-26-000381. Live rank is the latest 10-K on EDGAR (FY2026, period 2026-03-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.